A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome

Journal of Trauma - Injury, Infection and Critical Care

Volumn 57, Issue 1, 2004, Pages 171-174

  Dart IV, Benjamin W ^a   Cockerham, W Todd ^a   Torres, Carlos ^a   Kipikasa, Joseph H ^a   Maxwell, Robert A ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ABDOMINAL COMPARTMENT SYNDROME; ABDOMINAL DRAINAGE; ADULT; ARTICLE; BLADDER PRESSURE; BLEEDING; CASE REPORT; CLINICAL FEATURE; COMPARTMENT SYNDROME; DISEASE COURSE; ENDOTRACHEAL INTUBATION; FEMALE; HELLP SYNDROME; HUMAN; LIVER RUPTURE; PARACENTESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; DECOMPRESSION SURGERY; DIFFERENTIAL DIAGNOSIS; LIVER DISEASE; PREGNANCY; RUPTURE; SECOND TRIMESTER PREGNANCY;

ADULT; COMPARTMENT SYNDROMES; DECOMPRESSION, SURGICAL; DIAGNOSIS, DIFFERENTIAL; FACTOR VII; FEMALE; HELLP SYNDROME; HUMANS; LIVER DISEASES; PLATELET TRANSFUSION; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RECOMBINANT PROTEINS; RUPTURE, SPONTANEOUS;

EID: 4043087677     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000135142.80368.65     Document Type: Article

References (29)

1. Latenser BA, Kowal-Vern A, Kimball D, Chakrin A, Dujovny N. A pilot study comparing percutaneous decompressive laparotomy for acute abdominal compartment syndrome in thermal injury. J Burn Care Rehabil. 2002;23:190-195.
2. Pritchard JA, Weisman R, Ratnoff OD, Vosburgh GJ. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. N Engl J Med. 1954;250:89-98.
3. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1985;66:657-660.
4. Sheikh RA, Yasmeen S, Pauly MP, Riegler JL. Spontaneous intrahepatic hemorrhage and hepatic rupture in the HELLP syndrome. J Clin Gastroenterol. 1999;28:323-328.
5. Pereira SP, O'Donohue J, Wendon J, Williams R. Maternal and perinatal outcome in severe pregnancy-related liver disease. Hepatology. 1997;26:1258-1262.
6. Barton JR, Riely CA, Adamec TA, Shanklin DR, Khoury AD, Sibai BM. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol. 1992;167:1538-1243.
7. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN Jr. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1148-1153.
8. Stevenson JT, Graham DJ. Hepatic hemorrhage and the HELLP syndrome: a surgeon's perspective. Am Surg. 1995;61:756-760.
9. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990;162:311-316.
10. Loevinger EH, Vujic I, Lee WM, Anderson MC. Hepatic rupture associated with pregnancy: treatment with transcatheter embolotherapy. Obstet Gynecol. 1985;65:281-284.
11. Terasaki KK, Quinn MF, Lundell CJ, Finck EJ, Pentecost MJ. Spontaneous hepatic hemorrhage in preeclampsia: treatment with hepatic arterial embolization. Radiology. 1990;174:1039-41.
12. Erhard J, Lange R, Niebel W, et al. Acute liver necrosis in the HELLP syndrome: successful outcome after orthotopic liver transplantation-a case report. Transpl Int. 1993;6:179-181.
13. Hedner U. Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000. Semin Thromb Haemost. 2000;26:363-366.
14. Hedner U, Schulman S, Alberts KA, et al. Successful use of rFVIIa in a patient with severe hemophilia A subjected to synovectomy. Lancet. 1988;2:1193.
15. Chuansumrit A, Chantarojanasiri T, Isarangkura P, Teeraratkul S, Hongeng S, Hathirat P. Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation. Blood Coagul Fibrinolysis. 2000;11(suppl 1):101-105.
16. Vlot AJ, Ton E, Mackaay AJ, Kramer MH, Gaillard CA. Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII. Am J Med. 2000;108:421-423.
17. White B, McHale J, Ravi N. Successful use of recombinant FVIIa in the management of intractable post-surgical intra-abdominal haemorrhage. Br J Haematol. 1999;107:677-678.
18. Al Douri M, Shafi T, Al Khudairi D, et al. Effects of administration of recombinant activated factor VII (rFVIIa; Novoseven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis. 2000;11(suppl I):121-127.
19. Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma. 2001;51:431-439.
20. O'Neill PA, Bluth M, Gloster ES, et al. Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy. J Trauma. 2002;52:400-405.
21. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet. 1999;354:1879.
22. Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet. 2003;361:201-205.
23. Hendricks HG, Meijer K, de Wolf JT, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: A pilot study. Transplantation. 2001;71:402-405.
24. Jeffers LJ, Bernstein DE, Erhardsten E, et al. The use of recombinant factor VIIa in laparoscopy liver biopsy: a pilot trial [abstr]. Gastroenterology. 1998;114:L0275.
25. Salek SK, Sokolic V, Viskovic T, Sanjug J, Simic M, Kastelan M. Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome. Acta Haematol. 2002;108:162-163.
26. Veer CV, Mann KG. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders. Semin Thromb Haemost. 2000;26:367-372.
27. Monroe DM, Huffman M, Allen GA, Roberts HR. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Haemost. 2000;26:373-377.
28. Vidarsson B, Onundarson PT. Recombinant factor VIIa for bleeding in refractory thrombocytopenia. Tromb Haemost. 2000;83:634-635.
29. Kristensen J, Killander A, Hippe E, et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis. 1996;26(suppl 1):159-164.